2022 EULAR建议:风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理

2022-02-02 欧洲抗风湿病联盟 Ann Rheum Dis

2022年2月,欧洲抗风湿病联盟(EULAR)发布了风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理建议。

中文标题:

2022 EULAR建议:风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理

英文标题:

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

发布机构:

欧洲抗风湿病联盟

发布日期:

2022-02-02

简要介绍:

2022年2月,欧洲抗风湿病联盟(EULAR)发布了风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理建议。指南主要针对痛风、血管炎、系统性硬化、肌炎、混合性结缔组织病、干燥综合征、系统性红斑狼疮、以及抗磷脂综合症心血管风险的管理提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 EULAR建议:风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f6c8d1c0023a60ea, title=2022 EULAR建议:风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理, enTitle=EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome, guiderFrom=Ann Rheum Dis, authorId=0, author=, summary=2022年2月,欧洲抗风湿病联盟(EULAR)发布了风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理建议。, cover=https://img.medsci.cn/202227/1644247153815_1608702.jpg, journalId=0, articlesId=null, associationId=258, associationName=欧洲抗风湿病联盟, associationIntro=null, copyright=0, guiderPublishedTime=Wed Feb 02 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年2月,欧洲抗风湿病联盟(EULAR)发布了风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理建议。指南主要针对痛风、血管炎、系统性硬化、肌炎、混合性结缔组织病、干燥综合征、系统性红斑狼疮、以及抗磷脂综合症心血管风险的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=648, tagName=系统性红斑狼疮), TagDto(tagId=1567, tagName=心血管风险), TagDto(tagId=32989, tagName=抗磷脂综合征), TagDto(tagId=122597, tagName=风湿和肌肉骨骼疾病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21023, categoryName=赛诺菲-赛能, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4417, appHits=213, showAppHits=0, pcHits=495, showPcHits=4202, likes=1, shares=21, comments=3, approvalStatus=1, publishedTime=Tue Feb 08 15:20:00 CST 2022, publishedTimeString=2022-02-02, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Mon Feb 07 23:22:28 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 22:17:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 EULAR建议:风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理.pdf)])
2022 EULAR建议:风湿和肌肉骨骼疾病,包括系统性红斑狼疮和抗磷脂综合征的心血管风险管理.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1228468, encodeId=6dfb12284686a, content=非常有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/24/343ea812585a1cafa0e12fbf289b0da0.jpg, createdBy=a5722407852, createdName=飞白空间, createdTime=Fri Jun 24 16:43:58 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195826, encodeId=4caf1195826e3, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06515313, createdName=ms6000001219444008, createdTime=Mon Feb 21 20:49:52 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193884, encodeId=db0b119388420, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:51:37 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
    2022-06-24 飞白空间

    非常有意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1228468, encodeId=6dfb12284686a, content=非常有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/24/343ea812585a1cafa0e12fbf289b0da0.jpg, createdBy=a5722407852, createdName=飞白空间, createdTime=Fri Jun 24 16:43:58 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195826, encodeId=4caf1195826e3, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06515313, createdName=ms6000001219444008, createdTime=Mon Feb 21 20:49:52 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193884, encodeId=db0b119388420, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:51:37 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
    2022-02-21 ms6000001219444008

    好好学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1228468, encodeId=6dfb12284686a, content=非常有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/24/343ea812585a1cafa0e12fbf289b0da0.jpg, createdBy=a5722407852, createdName=飞白空间, createdTime=Fri Jun 24 16:43:58 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195826, encodeId=4caf1195826e3, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06515313, createdName=ms6000001219444008, createdTime=Mon Feb 21 20:49:52 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193884, encodeId=db0b119388420, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:51:37 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
    2022-02-16 龙珠

    学习好资料

    0